ARS Pharmaceuticals' Neffy nasal spray showed 89.2% success in treating anaphylaxis in 545 patients, comparable to epinephrine injections. FDA approved Neffy in 2024 for adults and children over 30 kg ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback